Day: January 4, 2024

GUANGZHOU, China, Jan. 04, 2024 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it has received written notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC (“NASDAQ”) dated December 29, 2023, indicating that for the last 30 consecutive business days, the closing bid price for the Company’s American depositary shares (the “ADSs”) was below the minimum bid price of US$1.00 per share requirement set forth in NASDAQ Listing Rule 5450(a)(1). The NASDAQ notification letter has no current effect on the listing or trading of the Company’s securities on NASDAQ. Pursuant to the NASDAQ Listing...

VANCOUVER, British Columbia, Jan. 03, 2024 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today provided unaudited 2023 production volumes for Quebrada Blanca (“QB”) operations, an update on the QB2 project, and unaudited fourth quarter steelmaking coal sales volumes and realized prices. “We are pleased that QB is now operating near design throughput capacity with strong recoveries, positioning Teck for significantly increased copper production in 2024,” said Jonathan Price, President and CEO. “We had strong fourth quarter performance in our steelmaking coal operations, with improvements in plant performance leading to an increase in production, and sales volumes of 6.1 million tonnes near the top end of our guidance.” QB Operations 2023 unaudited contained copper production volumes from...

Combined Company to Benefit from Anticipated Significant Expense Savings, Improved Scale and Capital Efficiency Represents Over $110 Million in Combined Total Assets and $65 Million in Combined Annual Revenue1 Charlotte, NC, Jan. 03, 2024 (GLOBE NEWSWIRE) — FG Financial Group, Inc. (Nasdaq: FGF, FGFPP) (“FG Financial”) and FG Group Holdings Inc. (NYSE American: FGH) (“FG Group Holdings”) today announced that they have signed a definitive plan of merger to combine the companies in an all-stock transaction. Upon completion of the merger, the combined company will be renamed to Fundamental Global Inc. and the common stock and Series A cumulative preferred stock of the combined company will continue to trade on the Nasdaq under the tickers “FGF” and “FGFPP,” respectively. With combined assets of over $110 million and combined annual...

LEXINGTON, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or “we”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ß”) family of proteins, today announced the pricing of an underwritten public offering of 3,500,000 shares of common stock, at a public offering price of $40.00 per share. The gross proceeds to Keros from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $140.0 million. All of the common stock is being offered by Keros. In addition, Keros has granted the underwriters a 30-day option to purchase up to an additional 525,000...

NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on developing novel therapies for a broad range of cancer indications, today announced that it intends to offer and sell shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase shares of common stock in a public offering. All of the securities to be sold in the offering are to be offered by SELLAS. The Company intends to use the net proceeds from the offering for funding of ongoing operations, including clinical development of existing product candidates, and for working capital and other general corporate purposes. A.G.P./Alliance Global Partners is acting as sole placement agent for the offering on a best-efforts...